Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-023657
Date:2021-03-26
Issuer: VIRACTA THERAPEUTICS, INC. (VIRX)
Original Submission Date:

Reporting Person:

DARCY THOMAS E
C/O VIRACTA THERAPEUTICS, INC.
2533 S COAST HWY 101, SUITE 210 CARDIFF, CA 92007

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 8.74 2021-03-26 deemed execution date A 80,000 (a) 2031-03-26 common stock 80,000 $8.74 80,000 direct
Footnotes
IDfootnote
f1 one thirty-sixth (1/36th) of the shares subject to the option shall vest on the one (1) month anniversary of march 1, 2021 (the "vesting commencement date"), and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the vesting commencement date (and if there is no corresponding day, on the last day of the month), subject to the reporting person continuing to be a service provider (as defined in the viracta therapeutics, inc. 2021 equity incentive plan) through each such date.
WhaleWisdom Logo

Elevate your investments